QC
BDSX icon

Quadrature Capital’s Biodesix BDSX Stock Holding History

Quadrature Capital’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Buy
+24,766
New +$367K ﹤0.01% 973

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Quadrature Capital's BDSX Position: Q2 2026 in Review

Quadrature Capital opened a new position in Biodesix (BDSX) in Q2 2026: 24,766 shares worth $558K. The stake represents ﹤0.01% of the portfolio and ranks #973 among its holdings.

45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Quadrature Capital held 24,766 shares of Biodesix worth $558K as of Q2 2026.
  • Biodesix was a new Quadrature Capital position in Q2 2026.
  • Biodesix made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #973 holding.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.